Pages that link to "Q37605057"
Jump to navigation
Jump to search
The following pages link to Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy (Q37605057):
Displaying 50 items.
- Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis (Q24185782) (← links)
- Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis (Q24185895) (← links)
- Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions (Q26744689) (← links)
- Management of overt hepatic encephalopathy (Q26830789) (← links)
- Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases (Q26852922) (← links)
- Definition and nomenclature of hepatic encephalopathy (Q27023733) (← links)
- Resting-state functional magnetic resonance imaging in hepatic encephalopathy: current status and perspectives (Q30762483) (← links)
- Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis (Q30841841) (← links)
- Longitudinal brain white matter alterations in minimal hepatic encephalopathy before and after liver transplantation (Q30845685) (← links)
- Pathogenesis, diagnosis, and treatment of hepatic encephalopathy (Q30907818) (← links)
- Altered pattern of spontaneous brain activity in the patients with end-stage renal disease: a resting-state functional MRI study with regional homogeneity analysis (Q31131451) (← links)
- The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy (Q33439413) (← links)
- Minimal hepatic encephalopathy (Q33440095) (← links)
- Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy (Q33440948) (← links)
- Comorbidity and dementia: A nationwide survey in Taiwan (Q33558758) (← links)
- Neurocognitive effects of HIV, hepatitis C, and substance use history (Q33652957) (← links)
- New assessment of hepatic encephalopathy (Q33767352) (← links)
- Persistence of cognitive impairment after resolution of overt hepatic encephalopathy (Q33905974) (← links)
- The role of microbiota in hepatic encephalopathy (Q34129402) (← links)
- Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis (Q34135613) (← links)
- Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy (Q34252801) (← links)
- Aberrant resting-state corticostriatal functional connectivity in cirrhotic patients with hyperintense globus pallidus on T1-weighted MR imaging (Q34473681) (← links)
- Disrupted functional connectivity of the anterior cingulate cortex in cirrhotic patients without overt hepatic encephalopathy: a resting state fMRI study (Q34544766) (← links)
- Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy (Q34658087) (← links)
- Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study (Q34787750) (← links)
- Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization (Q35064105) (← links)
- Classification of cirrhotic patients with or without minimal hepatic encephalopathy and healthy subjects using resting-state attention-related network analysis (Q35125147) (← links)
- Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls (Q35203206) (← links)
- Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining (Q35513402) (← links)
- Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity (Q35957942) (← links)
- Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy (Q35964960) (← links)
- Extrahepatic manifestations of hepatitis C infection: navigating CHASM. (Q36010828) (← links)
- Bacopa monnieri Extract (CDRI-08) Modulates the NMDA Receptor Subunits and nNOS-Apoptosis Axis in Cerebellum of Hepatic Encephalopathy Rats (Q36043633) (← links)
- Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study (Q36085443) (← links)
- Decreased Coupling Between Functional Connectivity Density and Amplitude of Low Frequency Fluctuation in Non-Neuropsychiatric Systemic Lupus Erythematosus: a Resting-Stage Functional MRI Study (Q36117913) (← links)
- Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure (Q36181170) (← links)
- Covert and Overt Hepatic Encephalopathy: Diagnosis and Management (Q36199772) (← links)
- Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis (Q36428010) (← links)
- Effect of obstructive sleep apnea on the sleep architecture in cirrhosis (Q36627779) (← links)
- Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis (Q36702499) (← links)
- Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study (Q36706010) (← links)
- Modified-orientation log to assess hepatic encephalopathy (Q36739173) (← links)
- Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy (Q36752000) (← links)
- Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study (Q37256639) (← links)
- Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China (Q37408898) (← links)
- Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial (Q37641048) (← links)
- Longitudinal Intrinsic Brain Activity Changes in Cirrhotic Patients before and One Month after Liver Transplantation (Q37647743) (← links)
- Driving Simulation Can Improve Insight into Impaired Driving Skills in Cirrhosis (Q37677018) (← links)
- PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis (Q37706741) (← links)
- The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers (Q37706747) (← links)